Despite decades of research establishing the safety and efficacy of cholesterol-lowering medications, adherence remains a ...

All chronic disease programs—including those targeting heart disease, obesity, diabetes, domestic HIV care ... of rural infrastructure. Food and Drug Administration (FDA): Funding set at ...

Q1 2025 Earnings Conference Call April 30, 2025 7:00 AM ETCompany ParticipantsConstantin Fest - Head of IREmma Walmsley - CEOLuke Miels ...

I’m the sexy sexagenarian. Then I’m gonna be the sexy septuagenarian, ha ha!’ - THE SATURDAY INTERVIEW: The punk rocker who ...

Gilead Sciences agreed to pay $202 million to settle a whistleblower lawsuit accusing the drugmaker of civil fraud for paying ...

Gilead Sciences on Thursday reported a first-quarter profit, but revenue was flat, as higher sales of drugs for HIV and liver ...

The company is looking to the highly anticipated launch of a closely watched HIV medicine to offset weakening demand for ...

Gilead Sciences to Pay $202 Million in US Settlement Over HIV Drug Kickbacks By Jonathan Stempel NEW YORK (Reuters) -Gilead Sciences agreed to pay $202 million to settle a whistleblower lawsuit ...

Lipids are the fatty molecules that make up cellular membranes, creating a protective barrier that regulates what enters and ...

People are falling ill because the U.S.-funded clinics where they got their HIV medications and care have suddenly been shuttered. The staff is gone. The electricity has been shut off. Some patients ...

For 15 years, Chanda has been meeting truckers in dusty parking lots at the border of Zambia and the Democratic Republic of Congo to give them their HIV medications. Now, he says, he doesn't know ...

Throughout all this, the administration has said that lifesaving medications for people with HIV would, however, continue to flow. But on the ground, we're hearing a very different story.